SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

55176 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-13

Study Completion Date

2022-11-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is possible that achieving adequate HPV vaccination coverage will allow cervical cancer to be virtually eliminated. This is a priority for Georgia, where the burden of mortality and morbidity from cervical cancer is high and the yearly prevalence of cervical cancer is 14.5 per 100,000 population.

The objective of the intervention evaluated is to increase the uptake of the 1st dose of the HPV vaccination in Georgia. The intervention aims to achieve this by providing a SMS reminder informed by behavioural insights (BI) to remind caregivers of girls between 10-12 years that their daughter is due the first dose of her HPV vaccination, share information about the vaccine, and encourage them to book an appointment to receive the vaccination. Four different SMS messages will be compared to no SMS message.

The evaluation will be a 5-arm randomised controlled trial (RCT) which aims to answer the research question: Does each of the designed BI-informed SMS reminders increase the uptake of the first dose of the HPV vaccination among eligible girls in Georgia, compared to no reminder? Our hypothesis is that SMS reminders will increase the uptake of HPV vaccination.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Making Effective Human Papillomavirus (HPV) Vaccine Recommendations

NCT02377843

Human Papillomavirus

COMPLETED NA

ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

NCT06535139

Papillomavirus Vaccines

RECRUITING NA

An Observational Study of GP Verbal Reminders Upon Cervical Screening

NCT04970394

COMPLETED

Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine

NCT04611022

Human Papilloma Virus

RECRUITING NA

An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women

NCT02464358

Human Papillomavirus Infection

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No SMS reminder

This group will receive no reminder

Group Type NO_INTERVENTION

No interventions assigned to this group

Short SMS with no additional information

Caregivers of girls eligible to receive the HPV vaccination in this group will receive an SMS reminder that states: "As per national immunization calendar your daughter is due her free human papilloma virus vaccine, which will protect her against cervical cancer. Contact your family doctor today to arrange an appointment."

Group Type EXPERIMENTAL